| 臺大學術典藏 |
2020-01-17T03:09:34Z |
On Assessment of Bioequivalence for Drugs with Negligible Plasma Levels
|
JEN-PEI LIU; Chow S.?C.; Liu J.?P.; Liu J.-P.;Chow S.-C. |
| 臺大學術典藏 |
2020-01-17T03:09:34Z |
Sample size determination for the two one-sided tests procedure in bioequivalence
|
Liu J.-p.;Chow S.-C.; Liu J.-p.; Chow S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2020-01-17T03:09:33Z |
Individual bioequivalence: Preface
|
Chow S.-C.; Liu J.-P.; Chow S.-C.; Liu J.-P.; JEN-PEI LIU |
| 臺大學術典藏 |
2020-01-17T03:09:33Z |
Comment
|
JEN-PEI LIU; Chow S.-C.; Liu J.-P.; Liu J.-P.;Chow S.-C. |
| 臺大學術典藏 |
2020-01-17T03:09:33Z |
Statistical considerations in bioequivalence trials
|
Chow S.-C.;Liu J.-P.; Chow S.-C.; Liu J.-P.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T08:10:19Z |
Statistical test for evaluation of biosimilarity in variability of follow-On biologics
|
Hsieh, T.-C.;Chow, S.-C.;Liu, J.-P.;Hsiao, C.-F.;Chi, E.; Hsieh, T.-C.; Chow, S.-C.; Liu, J.-P.; Hsiao, C.-F.; Chi, E.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T07:30:29Z |
Inference on treatment effects for targeted clinical trials under enrichment design
|
Liu, J.-P.;Lin Jr.;R.;Chow, S.-C.; Liu, J.-P.; Lin Jr.; R.; Chow, S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:57:50Z |
Statistical issues on the diagnostic multivariate index assay for targeted clinical trials
|
Liu, J.-P.;Chow, S.-C.; Liu, J.-P.; Chow, S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:24:53Z |
Some thoughts on individual bioequivalence
|
Liu, J.;Chow, S.-C.; Liu, J.; Chow, S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:24:53Z |
Meta-analysis for bioequivalence review
|
Chow, S.-C.;Liu, J.; Chow, S.-C.; Liu, J.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:24:53Z |
A two one-sided tests procedure for assessment of individual bioequivalence
|
Liu, J.;Chow, S.-C.; Liu, J.; Chow, S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T06:24:52Z |
Statistical evaluation of similarity factor f2 as a criterion for assessment of similarity between dissolution profiles
|
Liu, J.-P.;Ma, M.C.;Chow, S.-C.; Liu, J.-P.; Ma, M.C.; Chow, S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T05:18:18Z |
The impact of outlying subjects on decision of bioequivalence
|
Ki, F.Y.C.;Liu, J.-P.;Wang, W.;Chow, S.-C.; Ki, F.Y.C.; Liu, J.-P.; Wang, W.; Chow, S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T05:18:18Z |
Replicated crossover designs in bioavailability and bioequivalence trials
|
Liu, J.-P.;Chow, S.-C.; Liu, J.-P.; Chow, S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T05:18:18Z |
Current issues in bioequivalence trials
|
Chow, S.-C.;Liu, J.-P.; Chow, S.-C.; Liu, J.-P.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T04:49:26Z |
Recent statistical developments in bioequivalence trials - A review of the FDA guidance
|
Chow, S.-C.;Liu, J.-P.; Chow, S.-C.; Liu, J.-P.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T04:09:26Z |
Sample size determination for the two one-sided tests procedure in bioequivalence
|
Liu, J.-p.;Chow, S.-C.; Liu, J.-p.; Chow, S.-C.; JEN-PEI LIU |
| 臺大學術典藏 |
2018-09-10T04:09:26Z |
Bridging studies in clinical development
|
Liu, J.-P.; Chow, S.-C.; JEN-PEI LIU; Liu, J.-P.;Chow, S.-C. |
| 臺大學術典藏 |
2018-09-10T04:09:26Z |
On the assessment of variability in bioavailability/bioequivalence studies
|
Liu, J.-P.;Chow, S.-C.; Liu, J.-P.; Chow, S.-C.; JEN-PEI LIU |
| 國立臺灣大學 |
2009-12 |
Design and Analysis of Clinical Trials, 2nd Edition, Abbreviate Chinese Translation
|
Chow, S.C.; Liu, J.P. |
| 國立臺灣大學 |
2004-01 |
Design and Analysis of Clinical Trials. 2nd Ed.
|
Chow, S.C.; Liu, J.P. |
| 國立臺灣大學 |
2000-01 |
Design and Analysis of Bioavailability and Bioequivalence Studies, 2nd Ed.
|
Chow, S.C.; Liu, J.P. |
| 國立臺灣大學 |
1998-05 |
Design and Analysis of Clinical Trials, 1st Edition
|
Chow, S.C.; Liu, J.P. |
| 國立臺灣大學 |
1998-02 |
Design and Analysis of Animal Studies in Pharmaceutical Development
|
Chow, S.C.; Liu, J.P. |
| 國立臺灣大學 |
1997-11 |
Statistical Evaluation of f2 as a criterion for Assessment of Similarity between Dissolution Profiles
|
Liu, J.P.; Ma, M.C.; Chow, S.C. |
